Interdisciplinary team reveals how Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy

FHS
June 18, 2024
4:35 pm

A new paper from an interdisciplinary team at MUSC Hollings Cancer Center describes how the bacteria Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.

Exclusive: Biotech tools company raises $75M for protein manufacturing tech

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 16, 2024

Fix What’s Broken in Healthcare Is New AMA President’s Priority

Fixing the healthcare system’s problems will be a top priority of American Medical Association (AMA) President Bruce Scott, MD, an otolaryngologist from Louisville, Kentucky, who

June 18, 2024

Long-term, 30-year CVD risk may help inform therapy for stage 1 hypertension

A comparison of two risk prediction tools used to calculate an individual’s risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should

July 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.